Pfizer Stock Rises as 2025 Outlook in Line With Expectations

Key TakeawaysPfizer on Tuesday affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.The drugmaker expects revenue from $61 billion to $64 billion for both 2024 and 2025, and expects adjusted earnings per share to grow in 2025.Pfizer has returned to year-over-year revenue growth in its two most recent quarters for the first time since COVID vaccine sales peaked. Pfizer (PFE) shares rose Tuesday morning after the pharmaceutical company a ...